GLP-1 in Ohio (2026): Costs & Coverage
US$ 28.93
glp-1 weight loss side effects Adverse of class drugs. Gastrointestinal issues are Body Image Distortion After Weight
Description
10.14336/AD.2017.1001 264 WuX.LiS.XueP.LiY
Got your estimate
In Wegovy trials, hair loss was reported by about 2.5-3% of users versus about 1% on placebo, and it shows up more with larger weight loss
doi: 10.3389/fmed.2022.875430 Summary Keywords glucagon-like peptide-1 receptor agonist (GLP-1RA), incretin based therapy, glucose-depent insulinotropic peptide (GIP), dual agonists, tirzepatide, type 2 diabetes Citation Gallwitz B (2022) Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity
